NORTH BAY VILLAGE, Fla.--(BUSINESS WIRE)--April 26, 2006--Gary Macleod, Chief Executive Officer, announced that, “Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU - News) recently received notice of allowance for a third US patent on its flagship product, the AT-101, a non-invasive drug-free device that applies whole body vibration by moving a person lying on a platform repetitively head to foot about 140 times per minute. This new patent includes 151 claims pertaining to the scientific basis for the action of the device and its current and future medical applications, including its future use of whole body vibration in combination with drugs such as statins, L-Arginine, beta-blockers, etc. for pain relief as well as other potential therapeutic indications.” Mr. Macleod added that, “The Company intends to conduct a clinical trial of the AT-101 based on a protocol that FDA recently reviewed as part of a pre-IDE submission.”
